A detailed history of O'Rourke & Company, Inc transactions in Abbott Laboratories stock. As of the latest transaction made, O'Rourke & Company, Inc holds 2,304 shares of ABT stock, worth $239,662. This represents 0.15% of its overall portfolio holdings.

Number of Shares
2,304
Previous 2,180 5.69%
Holding current value
$239,662
Previous $240,000 9.17%
% of portfolio
0.15%
Previous 0.15%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 18, 2024

BUY
$109.52 - $120.96 $13,580 - $14,999
124 Added 5.69%
2,304 $262,000
Q4 2023

Jan 24, 2024

SELL
$90.19 - $110.4 $1,803 - $2,208
-20 Reduced 0.91%
2,180 $240,000
Q1 2023

May 12, 2023

SELL
$96.86 - $114.01 $581 - $684
-6 Reduced 0.27%
2,200 $223,000
Q4 2022

Feb 13, 2023

SELL
$95.06 - $111.52 $8,650 - $10,148
-91 Reduced 3.96%
2,206 $242,000
Q2 2022

Aug 12, 2022

BUY
$102.07 - $123.37 $9,798 - $11,843
96 Added 4.36%
2,297 $250,000
Q4 2021

Feb 16, 2022

BUY
$115.53 - $141.46 $254,281 - $311,353
2,201 New
2,201 $310,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $182B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track O'Rourke & Company, Inc Portfolio

Follow O'Rourke & Company, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of O'Rourke & Company, Inc, based on Form 13F filings with the SEC.

News

Stay updated on O'Rourke & Company, Inc with notifications on news.